Market Value4,992,282,000
Total Holdings135
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PRVA / Privia Health Group, Inc.
ICVX / Icosavax, Inc.
CLDX / Celldex Therapeutics, Inc.
EQRX / EQRx Inc
UTRS / Minerva Surgical, Inc.
ZY / Zymergen Inc
MGNX / MacroGenics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
ADMA / ADMA Biologics, Inc.
VRCA / Verrica Pharmaceuticals Inc.
EVH / Evolent Health, Inc.
SGHT / Sight Sciences, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
CNCE / Concert Pharmaceuticals Inc
OM / Outset Medical, Inc.
CINC / CinCor Pharma Inc
NUVB / Nuvation Bio Inc.
DAWN / Day One Biopharmaceuticals, Inc.
ISO / IsoPlexis Corp
AGRX / Agile Therapeutics, Inc.
ZYME / Zymeworks Inc.
NARI / Inari Medical, Inc.
PRVB / Provention Bio Inc
BBIO / BridgeBio Pharma, Inc.
ADPT / Adaptive Biotechnologies Corporation
TMCI / Treace Medical Concepts, Inc.
ALBO / Albireo Pharma Inc
PHVS / Pharvaris N.V.
TARS / Tarsus Pharmaceuticals, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
RPID / Rapid Micro Biosystems, Inc.
RKLY.WS / Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an e
GRPH / Graphite Bio, Inc.
LUNG / Pulmonx Corporation
RAIN / Rain Enhancement Technologies Holdco, Inc.
US19459JAA25 / COLLEGIUM PHARMACEUTICAL INC CONV 2.625% 02/15/2026
US63009RAD17 / NanoString Technologies Inc
ONCR / Oncorus, Inc.
SUMMIT HEALTHCRE ACQUISTN CO / UNIT 06/03/2026 (G8566R128)
US89422GAA58 / Travere Therapeutics, Inc.
SRZN / Surrozen, Inc.
US83444K1135 / SomaLogic Inc
DALS / DA32 Life Science Tech Acquisition Corp - Class A
IMRX / Immuneering Corporation
US19249HAB96 / CHRS 1 1/2 04/15/26
BLSA / BCLS Acquisition Corp - Class A
/ Cue Health, Inc.
US26886C1154 / EQRx Inc
BFLY.WS / Butterfly Network, Inc. - Equity Warrant
HMIN / Homeinns Hotel Group
ITOS / iTeos Therapeutics, Inc.
RCUS / Arcus Biosciences, Inc.
DCPH / Deciphera Pharmaceuticals, Inc. Call
NVTA / Invitae Corporation
VERU / Veru Inc.
ARNA / Arena Pharmaceuticals Inc
AXNX / Axonics, Inc.
BIIB / Biogen Inc.
RACE / Ferrari N.V.
SLGC / Standard BioTools Inc.
BLU / Bellus Health Inc
CCXI / ChemoCentryx Inc
EIGR / Eiger BioPharmaceuticals, Inc.
KOD / Kodiak Sciences Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
CHRS / Coherus Oncology, Inc.
UTHR / United Therapeutics Corporation
VTRS / Viatris Inc.
MOTS / Motus GI Holdings, Inc.
ATXS / Astria Therapeutics, Inc.
ISEE / IVERIC bio Inc
NEPT / Neptune Wellness Solutions Inc.
HZNP / Horizon Therapeutics Plc
SLDB / Solid Biosciences Inc.
CCCC / C4 Therapeutics, Inc.
LSAQ / LifeSci Acquisition II Corp
SONX / Sonendo, Inc.
HYPR / Hyperfine, Inc.
SMFR / Sema4 Holdings Corp - Class A
LIANY / LianBio - Depositary Receipt (Common Stock)
RACB / Research Alliance Corp II - Class A
PRTA / Prothena Corporation plc
RLAY / Relay Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
VYNE / VYNE Therapeutics Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
CLOV / Clover Health Investments, Corp.
HCAT / Health Catalyst, Inc.
DICE / DICE Therapeutics Inc
TARA / Protara Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
CMAX / CareMax, Inc.
QTNT / Quotient Ltd
PEAR / Pear Therapeutics Inc - Class A
MORF / Morphic Holding, Inc.
ABSI / Absci Corporation
SAVA / Cassava Sciences, Inc. Put
DRIO / DarioHealth Corp.
PRCT / PROCEPT BioRobotics Corporation
RETA / Reata Pharmaceuticals Inc - Class A
KRON / Kronos Bio, Inc.
VBIV / VBI Vaccines Inc.
IMTX / Immatics N.V.
LABP / Landos Biopharma, Inc.
PNT / POINT Biopharma Global Inc.
OMIC / Singular Genomics Systems, Inc.
TVTX / Travere Therapeutics, Inc.
NVRO / Nevro Corp.
RXDX / Prometheus Biosciences Inc
MDGL / Madrigal Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc.
FUSN / Fusion Pharmaceuticals Inc.
COGT / Cogent Biosciences, Inc.
INBX.V / Inhibrx, Inc.
GBT / Global Blood Therapeutics Inc.
MRUS / Merus N.V.
FOLD / Amicus Therapeutics, Inc.
ATNX / Athenex Inc
MRTX / Mirati Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
ALDX / Aldeyra Therapeutics, Inc.
PEN / Penumbra, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
TYRA / Tyra Biosciences, Inc.
ACRS / Aclaris Therapeutics, Inc.
NVNO / enVVeno Medical Corporation
IOVA / Iovance Biotherapeutics, Inc.
NUVL / Nuvalent, Inc.
NBIX / Neurocrine Biosciences, Inc.
LPTX / Leap Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
AORT / Artivion, Inc.
NAUT / Nautilus Biotechnology, Inc.
RVNC / Revance Therapeutics, Inc.
LYRA / Lyra Therapeutics, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
SWTX / SpringWorks Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
MGTX / MeiraGTx Holdings plc
CMAXW / CareMax Inc - Warrants (08/06/2026)
FULC / Fulcrum Therapeutics, Inc.
PYXS / Pyxis Oncology, Inc.
XENE / Xenon Pharmaceuticals Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
CRNX / Crinetics Pharmaceuticals, Inc.
ATHA / Athira Pharma, Inc.
NBTX / Nanobiotix S.A. - Depositary Receipt (Common Stock)